2016 BIOPACIFIC CONFERENCE by CABS (Early Bird Registration by 04/15/16)

anonymous-100082  04/14   3698  
4.0/1 

2016 BIOPACIFIC CONFERENCE by CABS (Early Bird Registration by 04/15/16)
Date: May 7, 2016 @ 8:00 am – @ 9:00 pm
Location: San Mateo Marriott, 1770 South Amphlett Blvd, San Mateo, CA 94402

Early Bird Registration by 04/15/16 (click the link below)

http://www.cabsweb.org/events/2143408/Registration+is+Open%3A+2016+BioPacific+Conference/

18th Annual Conference of the Chinese American BioPharmaceutical Society & Inaugural BioPacific Partnering

Our meeting will showcase:
·         Winner of 2016 CABS K. Fong Award in Life Sciences: Dr. Gerald Chan, co-founder of Morningside
·         Success stories of entrepreneurs and emerging companies including Adheron Therapeutics and PaxVax
·         Most promising areas in life sciences including cancer immunotherapy and CRISPR/dCas9 technology
·         BioPharmaceutical Development - China & Global Considerations
·         US-China Cross-Border Healthcare Investment & Entrepreneurship
·         Two-day BioPacific Forum to facilitate interactions including project introduction and talent recruitment between attendees and sponsors

Confirmed speakers and panelists:
•  Dr. Gerald Chan, Co-founder, Morningside
•  Hari Kumar, CEO, Adheron Therapeutics
•  Piers Whitehead, EVP & CBO, PaxVax 
•  Mark Selby, Ph.D., Senior Director of Immuno-Oncology, Bristol-Myers Squibb
•  Lei Stanley Qi, Ph.D., Assistant Professor, Stanford University School of Medicine 
•  Darren Ji, Ph.D.,MBA,  Vice President and Global Head, Roche Partnering Asia and Emerging Markets
•  Tom Irving, J.D., Partner & Wen Li, Ph.D., Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
•  Robert Lou, Manager Director, Ningbo Kangtaibo Technology Development Co. Ltd
•  Hui Zhang, Deputy Director, Ningbo Hangzhou Bay New Zone Investment and Partnership Branch
•  Jinqun Yin, MBA, Vice President, Chengdu Kanghong Pharmaceutical Group Co., Ltd
•  Charles C. Comey, J.D., Partner, Morrison & Foerster
•  Shawn Qian, Ph.D., CEO, Neupharma
•  Xiaodong Yang, M.D., Ph.D., President and CEO, Apexigen
•  Xian-Ping Lu, Ph.D., Co-Founder, CEO and CSO, Chipscreen Biosciences
•  Dan Zhang, M.D., Ph.D., CEO, Fountain Medical Development
•  Connie Sun, Ph.D, Senior Vice President, Business and Corporate Development, Pharmaron
•  Cheni Kwok, Ph.D, CLP Senior Consultant, Medicilon, Managing Partner, Linear Dreams
•  Alexis Ji, Ph.D., MBA, Principal, WuXi Healthcare Ventures
•  James Zhao, M.D., M.S., MBA, Founding Partner, LYFE Capital
•  Yuwen Liu, MBA, MS, Founding Partner, BoHe Angel Fund
•  Min Cui, Ph.D., Founding Partner and Managing Director,  Decheng Capital
•  Vincent Liu, Ph.D., MBA, Senior Consultant, Wanbang Biopharmaceutical Shanghai Fosun Pharmaceutical (Group) Co., Ltd
•  Shawn Lee, Ph.D. Vice- Chairman, Xinbang Pharmaceutical, President & CEO, CPC Scientific Inc.  
•  Cheng Liu, Ph.D., Founder and CEO, Eureka Therapeutics
•  Jennifer Hu, Ph.D., Venture Partner, Qiming Venture Partners

See conference agenda at:
http://biopacificconference.org/